Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gattermann

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Photochemistry and Photobiology|August 1, 1997
Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic systemM Berneburg, N Gattermann, H Stege, et al.
Blood|January 7, 1998
Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemiaN Gattermann, S Retzlaff, Y L Wang, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Severe impairment of nucleotide synthesis through inhibition of mitochondrial respirationN Gattermann, M Dadak, G Hofhaus, et al.
British Journal of Haematology|October 29, 2000
Long-term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesisM Aivado, A Rong, U Germing, et al.
Leukemia Research|August 8, 2006
Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidineA Kuendgen, T Gräf, F Zohren, et al.
British Journal of Haematology|June 1, 1996
A heteroplasmic point mutation of mitochondrial tRNALeu(CUN) in non-lymphoid haemopoietic cell lineages from a patient with acquired idiopathic sideroblastic anaemiaN Gattermann, S Retzlaff, Y L Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patientsT Schroeder, L Ruf, A Bernhardt, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 2001
[Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]B E Strauer, M Brehm, T Zeus, et al.
Annals of Hematology|November 21, 2022
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blastsA Kasprzak, C Assadi, K Nachtkamp, et al.
Praxis|April 13, 1999
[Role of aggressive treatment strategies for myelodysplastic syndromes]C Aul, U Germing, H Minning, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Photochemistry and Photobiology|August 1, 1997
Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic systemM Berneburg, N Gattermann, H Stege, et al.
Blood|January 7, 1998
Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemiaN Gattermann, S Retzlaff, Y L Wang, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Severe impairment of nucleotide synthesis through inhibition of mitochondrial respirationN Gattermann, M Dadak, G Hofhaus, et al.
British Journal of Haematology|October 29, 2000
Long-term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesisM Aivado, A Rong, U Germing, et al.
Leukemia Research|August 8, 2006
Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidineA Kuendgen, T Gräf, F Zohren, et al.
British Journal of Haematology|June 1, 1996
A heteroplasmic point mutation of mitochondrial tRNALeu(CUN) in non-lymphoid haemopoietic cell lineages from a patient with acquired idiopathic sideroblastic anaemiaN Gattermann, S Retzlaff, Y L Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patientsT Schroeder, L Ruf, A Bernhardt, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 2001
[Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]B E Strauer, M Brehm, T Zeus, et al.
Annals of Hematology|November 21, 2022
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blastsA Kasprzak, C Assadi, K Nachtkamp, et al.
Praxis|April 13, 1999
[Role of aggressive treatment strategies for myelodysplastic syndromes]C Aul, U Germing, H Minning, et al.
Pageof 11